Background: Total lymphoid irradiation (TLI) plays a role in the conditioning of hematopoietic stem cell transplantation (HSCT) from non-sibling donors for severe aplastic anemia (SAA) patients. For the past decades, an anterior-posterior opposed technique has been used to deliver TLI. We present our singleinstitution experience of helical tomotherapy TLI.Methods: From October 2014 to February 2019, three consecutive patients of SAA who underwent tomotherapy TLI for pre-transplantation conditioning were enlisted. We retrospectively analyzed the survival, engraftment outcome, and toxicities of these patients and created a conventional TLI plan with anterior-posterior opposed fields for each patient to compare the dosimetry difference between helical tomotherapy and the conventional technique.Results: Among all three patients, the engraftment rate was 100%. The 18-month overall survival and event-free survival were both 66.7% among the 3 patients (2 underwent unrelated donor transplantation and 1 underwent haplo-identical related donor transplantation), and 100% for the patients who received transplantation from matched-or mismatched-unrelated donors. No patient experienced acute grade 3 or worse graft-versus-host disease (GVHD), and none of the three patients suffered from late GVHD. No significant acute or late adverse events of radiation were observed. Tomotherapy-based TLI provides better target volume coverage with an average 10% higher coverage along with greater sparing of normal tissues.The total body volume exposed to 5 Gy was an average 35% lower in the tomotherapy-based TLI.Conclusions: TLI with non-ablative conditioning regimen provided excellent engraftment and an acceptable survival in the SAA patients who underwent non-sibling donor HSCT.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.